|
|
 |
Respiratory agent
|
 |
Respiratory inhalant product
|
 |
Corticosteroid-dependent Asthma, Local treatment of symptoms of seasonal allergy.
|
 |
(Adults) 2 sprays in each nostril twice daily. If needed, may increase dose to 2 sprays in each nostril 3 times daily. (Pediatric patients 6 to 14 years) 1 spray into each nostril 3 times daily or 2 sprays into each nostril twice daily. (Pediatric patients <6 years) Not recommended.
|
 |
Category C.
|
 |
Nasal burning or stinging, congestion, sneezing, irritation, watery eyes, sore throat, nervousness, nasopharyngeal fungal infection, upper respiratory tract infection, pruritus.
|
Pregnancy Risk Categories defined:
A: Studies in pregnant women failed to show a risk to the fetus in the first
trimester - with no evidence of risk in the later trimesters.
B: Animals studies indicate no adverse effect to the fetus, but there are no adequate,
clinical studies in pregnant women.
C: Animal studies have shown an adverse effect on the fetus, but there are no adequate,
clinical studies in humans. Despite potential risks, the drug may be useful in pregnant
women.
D: There is evidence of risk to the human fetus, but the potential benefits of use in
pregnant women may be acceptable, despite potential risks.
X: Studies in animals or humans show fetal abnormalities, or adverse reaction reports
indicate evidence of fetal risk. Warning: the risks involved clearly outweigh any
potential benefit from using the drug in pregnant women, regardless of trimester.
NR: Not rated (i.e., no information available at this time as to the potential
risks or benefits).
|
| | |
If you want your friend to read or know about this article, Click here
 |
|
|
